glp 1 agonists and pancreatitis Updates in Medicine | GLP-1s may raise risk early—but over time, protective effects balance the scale, resulting in no increase in overall 1-year risk Emergency Medicine Ottawa | 🚨

And then oral and transdermal, it didn't seem to make a difference

Lesser known is their impact on eye health and vision, which ranges from mild blurriness to rare and more serious conditions

Rodriguez, conducted a cohort study involving 125,474 patients who started GLP-1 medications, including Victoza (liraglutide), Ozempic and Wegovy, and Mounjaro and Zepbound between January 1, 2018 and December 31, 2023

165,166 The C max and AUC values of ethinylestradiol and levonorgestrel were not affected by the administration of 14 mg oral or 1 mg subcutaneous semaglutide, indicating that it is not clinically relevant (Table 4)

1.5% vs 0.9%point), dulaglutide (semaglutide 0.5 mg vs dulaglutide 0.75 mg, 1.5% vs 1.1%point

Once weekly (OW) semaglutide is used as an example to illustrate how the authors might switch to a different GLP1RA in clinical practice